Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment
Manni Wang, Yu Liu, Yuan Cheng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1871, Iss. 2, pp. 199-224
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 293
Breast cancer models: Engineering the tumor microenvironment
Gökhan Bahçecioğlu, Gozde Basara, Bradley W. Ellis, et al.
Acta Biomaterialia (2020) Vol. 106, pp. 1-21
Open Access | Times Cited: 165
Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
Yanlin Song, Zhenfei Bi, Yu Liu, et al.
Genes & Diseases (2022) Vol. 10, Iss. 1, pp. 76-88
Open Access | Times Cited: 109
3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip
Wenxiu Li, Zhihang Zhou, Xiaoyu Zhou, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 18
Open Access | Times Cited: 51
Hypoxia-induced epithelial to mesenchymal transition in cancer
Robert Hapke, Scott M. Haake
Cancer Letters (2020) Vol. 487, pp. 10-20
Open Access | Times Cited: 127
Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8/PD-L1 signaling in NSCLC
Wenjing Liu, Lin Wang, Feng-Mei Zhou, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100987-100987
Open Access | Times Cited: 30
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers
S Mestiri, Dina Moustafa Abo El-Ella, Queenie Fernandes, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116095-116095
Open Access | Times Cited: 8
Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
Gloria Manzotti, Alessia Ciarrocchi, Valentina Sancisi
Cancers (2019) Vol. 11, Iss. 3, pp. 304-304
Open Access | Times Cited: 74
Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade
Min Hwa Shin, Jiyoung Kim, Siyoung A. Lim, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2531-2531
Open Access | Times Cited: 67
Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics
Colin G. Buss, Sangeeta N. Bhatia
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 24, pp. 13428-13436
Open Access | Times Cited: 59
Roles of exosomal circRNAs in tumour immunity and cancer progression
Baojing Tuo, Zhuang Chen, Qin Dang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 29
Recent progress in combination therapy of oncolytic vaccinia virus
Seyedeh Nasim Mirbahari, Miles Da Silva, Abril Ixchel Muñoz Zúñiga, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Triterpenoids-templated self-assembly nanosystem for biomimetic delivery of CRISPR/Cas9 based on the synergy of TLR-2 and ICB to enhance HCC immunotherapy
Bingchen Zhang, Chunmei Lai, Bang-Yue Luo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3205-3217
Open Access | Times Cited: 6
Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors
Maxim Shevtsov, Gabriele Multhoff, Elena R. Mikhaylova, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5284-5284
Open Access | Times Cited: 53
QSP‐IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno‐Oncology Applications
Richard J. Sové, Mohammad Jafarnejad, Chen Zhao, et al.
CPT Pharmacometrics & Systems Pharmacology (2020) Vol. 9, Iss. 9, pp. 484-497
Open Access | Times Cited: 45
EZH2 is a potential prognostic predictor of glioma
Yinan Chen, Shiqiang Hou, Rui Jiang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 925-936
Open Access | Times Cited: 43
The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Jiji V. D. Attia, Charlotte E. Dessens, Ricky B. van de Water, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8678-8678
Open Access | Times Cited: 40
Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy
Yundi Chen, Lixue Wang, Mingfeng Zheng, et al.
Bioactive Materials (2021) Vol. 9, pp. 251-265
Open Access | Times Cited: 39
Transcutaneous tumor vaccination combined with anti-programmed death-1 monoclonal antibody treatment produces a synergistic antitumor effect
Xinran Song, Yuxin Jiang, Weixing Zhang, et al.
Acta Biomaterialia (2021) Vol. 140, pp. 247-260
Closed Access | Times Cited: 37
Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
Seung Mo Jin, Sang Nam Lee, Jung Eun Kim, et al.
Advanced Science (2021) Vol. 8, Iss. 19
Open Access | Times Cited: 35
Noncanonical immune response to the inhibition of DNA methylation by Staufen1 via stabilization of endogenous retrovirus RNAs
Yongsuk Ku, Joo‐Hwan Park, Ryeongeun Cho, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 13
Open Access | Times Cited: 34
PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
Yingzi Zhang, Yan Yang, Yiran Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
A transcriptome based molecular classification scheme for cholangiocarcinoma and subtype-derived prognostic biomarker
Zhongqi Fan, Xinchen Zou, Guangyi Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance
Xiaolin Wu, Nuan Feng, Chao Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top